- Home
- USAU vs OPTN Comparison
USAU vs OPTN Comparison
Compare USAU & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAU
- OPTN
- Stock Information
- Founded
- USAU N/A
- OPTN 2010
- Country
- USAU United States
- OPTN United States
- Employees
- USAU N/A
- OPTN N/A
- Industry
- USAU Precious Metals
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- USAU Basic Materials
- OPTN Health Care
- Exchange
- USAU Nasdaq
- OPTN Nasdaq
- Market Cap
- USAU 68.1M
- OPTN 78.4M
- IPO Year
- USAU N/A
- OPTN 2017
- Fundamental
- Price
- USAU $6.83
- OPTN $0.45
- Analyst Decision
- USAU Strong Buy
- OPTN Strong Buy
- Analyst Count
- USAU 1
- OPTN 3
- Target Price
- USAU $13.00
- OPTN $3.00
- AVG Volume (30 Days)
- USAU 201.5K
- OPTN 1.2M
- Earning Date
- USAU 12-16-2024
- OPTN 11-12-2024
- Dividend Yield
- USAU N/A
- OPTN N/A
- EPS Growth
- USAU N/A
- OPTN N/A
- EPS
- USAU N/A
- OPTN N/A
- Revenue
- USAU N/A
- OPTN $75,672,000.00
- Revenue This Year
- USAU N/A
- OPTN $13.42
- Revenue Next Year
- USAU N/A
- OPTN $52.99
- P/E Ratio
- USAU N/A
- OPTN N/A
- Revenue Growth
- USAU N/A
- OPTN 5.13
- 52 Week Low
- USAU $3.20
- OPTN $0.32
- 52 Week High
- USAU $8.62
- OPTN $2.10
- Technical
- Relative Strength Index (RSI)
- USAU 44.97
- OPTN 39.55
- Support Level
- USAU $6.51
- OPTN $0.42
- Resistance Level
- USAU $7.48
- OPTN $0.57
- Average True Range (ATR)
- USAU 0.40
- OPTN 0.05
- MACD
- USAU -0.16
- OPTN 0.00
- Stochastic Oscillator
- USAU 18.71
- OPTN 26.39
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.